StonvexLoading…
StonvexStonvexStonvexCore line items from DAN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $1.93B | $1.87B | $7.50B | $1.92B | $1.94B |
Operating Income | Not available | $19.00M | $139.00M | $77.00M | $24.00M |
Net Income | Not available | $1.09B | $85.00M | $83.00M | $27.00M |
EPS (Diluted) | $0.62 | $9.89 | $0.64 | $0.64 | $0.19 |
Total Assets | Not available | $6.08B | $7.81B | $8.11B | $8.14B |
Total Liabilities | Not available | $4.06B | $6.91B | $6.77B | $6.68B |
Cash & Equivalents | Not available | $477.00M | $469.00M | $414.00M | $486.00M |
Free Cash Flow OCF − CapEx | Not available | $-257.00M | $298.00M | $-47.00M | $-109.00M |
Shares Outstanding | Not available | 108.83M | 112.28M | 121.92M | 131.13M |